- Home
- JFU vs PRPH Comparison
JFU vs PRPH Comparison
Compare JFU & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFU
- PRPH
- Stock Information
- Founded
- JFU 2006
- PRPH 1989
- Country
- JFU China
- PRPH United States
- Employees
- JFU N/A
- PRPH N/A
- Industry
- JFU Finance: Consumer Services
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- JFU Finance
- PRPH Health Care
- Exchange
- JFU Nasdaq
- PRPH Nasdaq
- Market Cap
- JFU 16.5M
- PRPH 14.7M
- IPO Year
- JFU 2019
- PRPH 1997
- Fundamental
- Price
- JFU $1.39
- PRPH $0.76
- Analyst Decision
- JFU
- PRPH Strong Buy
- Analyst Count
- JFU 0
- PRPH 1
- Target Price
- JFU N/A
- PRPH $11.00
- AVG Volume (30 Days)
- JFU 16.2K
- PRPH 277.3K
- Earning Date
- JFU 11-29-2024
- PRPH 11-13-2024
- Dividend Yield
- JFU N/A
- PRPH N/A
- EPS Growth
- JFU N/A
- PRPH N/A
- EPS
- JFU 0.09
- PRPH N/A
- Revenue
- JFU $40,614,155.00
- PRPH $12,753,000.00
- Revenue This Year
- JFU N/A
- PRPH $36.93
- Revenue Next Year
- JFU N/A
- PRPH $132.05
- P/E Ratio
- JFU $13.73
- PRPH N/A
- Revenue Growth
- JFU N/A
- PRPH N/A
- 52 Week Low
- JFU $1.13
- PRPH $0.66
- 52 Week High
- JFU $4.90
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- JFU 39.39
- PRPH 19.28
- Support Level
- JFU $1.13
- PRPH $0.72
- Resistance Level
- JFU $1.51
- PRPH $0.83
- Average True Range (ATR)
- JFU 0.16
- PRPH 0.13
- MACD
- JFU -0.02
- PRPH -0.05
- Stochastic Oscillator
- JFU 34.48
- PRPH 7.45
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.